Imidazole Nucleosides and Nucleotides - ACS Publications

Imidazole Nucleosides and Nucleotides. Leroy B. Townsend. Chem. Rev. , 1967, 67 ... Sundberg and Martin. 1974 74 (4), pp 471–517. Abstract | PDF w/ ...
2 downloads 0 Views 2MB Size
IMIDAZOLE NUCLEOSIDES AND NUCLEOTIDES LEROY B. TOWNSEND

Department of Chemistry, University of Utah, Salt Lake City, Utah 84118 Received January 85, 1961 CONTENTS

I. Introduction, Scope, and Nomenclature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Chemical Synthesis of Imidazole Nucleosides and Nucleotides, .........................

111. IV.

V.

VI. VII.

533 534 A. Condensations of Heavy Metal Salts of Preformed Imidazoles with Acylglycosyl Halides 534 B. Ring Closure of Glycosylamines.. .............................................. 538 C. Degradation or Ring Opening of Purine Nucleosides and Nucleotides.. . . . . . . . . . . . . . . 541 546 D. Acid-Catalyzed Fusion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Miscellaneous. . ..................... 547 Imidazole Nucleosid ucleotide Biosynthesis, . . . . . . 547 Other Naturally Occurring Imidazole Nucleosides and Nucleotides. ........ 550 A. Histidine Biosynthesis. ........................................................ 550 B. Substituted Imidazole-Adenine Dinucleoside Pyrophosphates (Coenzyme Analogs). . . 551 C. Histamine Biosynthesis and Metabolism.. ....................................... 552 552 D. Alkaloids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Miscellaneous.. . . ............................ . . . . . . . . . 553 554 2’-Deoxyribofuran es . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 554 Tables ........... .............................. 561 References.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

I. INTRODUCTION, SCOPE,AND NOMENCLATURE This review covers the area of synthetic and naturally occurring imidazole nucleosides, nucleotides, and various related derivatives. Certain biochemical aspects of these compounds are also reviewed briefly. This ring system has been designated as glyoxaline, iminazole, l,&diazole, and imidazole. The first preparation of the parent ring system was accomplished (57) from ammonia and glyoxal; hence the origin of the term glyoxaline is self-evident and is still used extensively in some areas. The terms iminazole and 1,3-diazole are very rarely used in the recent literature. Imidazole, which is the term (83) applied most frequently to this ring system, indicates a five-membered heterocyclic ring system containing an imino group and a tertiary nitrogen and will be used throughout this review. It was originally proposed (108) that the term nucleoside be used only for carbohydrate derivatives of purines and pyrimidines isolated from the alkaline hydrolyzates of yeast nucleic acid. This was found t o limit the use of this term since the major carbohydrate constituents of yeast nucleic acid are either Dribose or 2-deoxy-~-erythro-pentose (2-deoxy-~-ribose). It has now been generally accepted that the term purine nucleoside refers to all glycosyl derivatives of purines, both synthetic and natural, and it seems logical at this time to extend this concept of terminology to encompass the entire field of nitrogen heterocycles. Therefore, in this review all glycosyl derivatives (133) of imidazoles, regardless of the nature of the carbohy533

drate moiety, will be referred to as imidazole nucleosides. The term imidazole nucleotide will be used when a phosphate ester has been formed on a hydroxy group of the carbohydrate moiety of an imida~ole nucleoside. The numbering system will use numerals to designate positions on the aglycon and primed numerals for positions on the carbohydrate moiety. Numbering of the aglycon always begins at the substituted nitrogen and proceeds so that the second nitrogen in the ring is at position 3. Numbering of the carbohydrate moiety originates a t the anomeric carbon which is the carbon involved in the glycosidic linkage.

A number of reviews have (26, 47, 79, 85, 125, 149) presented some imidazole nucleoside and nucleotide chemistry or biochemistry but only in connection with another subject. It is the object of this review to summarize and complement these previous reports and present a complete and comprehensive review on imidazole nucleosides and nucleotides. The generally accepted nomenclature (68, 133) has been used in this review. The literature survey pertaining to this re-

LEROYB. TOWNSEND

534

view was essentially concluded in June 1966 although a few more recent references have been included.

11. CHEMICAL SYNTHESIS OF IMIDAZOLE NUCLEOSIDES AND NUCLEOTIDES The chemical preparation of imidazole nucleosides is a relatively new area in comparison to the related areas of purine and pyrimidine nucleosides. The discovery that nucleic acids contained purine and pyrimidine nucleotides generated an early interest in the chemical synthesis of analogs of these naturally occurring compounds. Interest in the area of imidazole nucleosides and nucleotides developed rather slowly but has recently escalated rapidly. The major factor involved in this increased interest can probably be attributed to the fact that the major purine nucleotides found in nucleic acids depend on imidazole nucleotides as precursors. A.

CONDENSATIONS OF HEAVY METAL SALTS OF

PREFORMED IMIDAZOLES WITH ACYLGLYCOSYL HALIDES

The first reported chemical synthesis of an imidazole nucleoside was accomplished in connection with the elucidation of the site of glycosidic attachment of purine nucleosides isolated from nucleic acid. The condensation of a-acetobromoglucose (I) with the silver salt of 5(4)-methylimidazole (11) in a non+

polar solvent produced (80) the first crystalline synthetic imidazole nucleoside, 5-methyl-1-(2’,3’,4’,6’tetra-0-acetyl-fi-D-glLl Co p y r an0 s yl)imi d azo1e (111). Elucidation of the site of glycosidation was accomplished by alkylation of I11 with methyl iodide to afford a methiodide derivative of IV. Conversion of IV to the methochloroaurate derivative (V) followed by acid hydrolysis resulted in the isolation of 1,4-dimethylimidazole chloroaurate (VI). The structure of VI was established by a comparison of its solubility and melting point with the previously prepared (143) 1,4- and 1,5-dimethylimidazole chloroaurates and corroborated the initially assigned site of glycosidation. The stability of imidazole nucleosides was firmly established when V was recovered unchanged after refluxing in 21% hydrochloric acid for 1.5 hr; 38% hydrochloric acid at 150” for 2 hr was finally required to cleave the glycosidic bond. Although I11 was the only crystalline nucleoside isolated, it was suggested that the isomeric compound, 4-methyI-1-(2’,3’,4’,6’-tetra-O-acetylfi-D-ghcopyranosyl)imidazole (VII), was present in the mother liquor of the original reaction mixture. This type of condensation with subsequent deacetylaCH3300

171-172

Recryst solvent

deg (solvent)c

Triturated with ethanol

+78 (d)

Spectra

32

I11

161

Paper chromatogmphy

VI

36

Paperchromatography

I11

36

v Paperchromatography Bariumsalt

V

120 92

VI

170

I1

165

I11

162

Ethanol-water

UV

uv

K B

Water-acetone As above

-26.3 (0)

P p t d out of water with ethanol

I 186-187 dec

UV UV

Water

Hoco 207-209

HO

Ref

VI

UV IR

As above

HOOCCH,-P+JNJ HOOCdHz HzN

Mixd

Method of prepd

Aqueoua (pH 5)

OH

UV

Paperchromatography

I11

183

UV

Paperchromatography Paperchromatography Paperchromatography

I11

183

I11

183

I11

183

VI

162

As above

2'-Phosphate 3'-Phosphate

UV UV

6'-Phosphate 186-187

Ethanol-water

As above 0

II

0

Water, pptd with ethanol Water, pptd with ethanol

HO- P- 0-CH, bH

HO

OH

172 dec

Bariumsalt

VI

168

UV

Barium salt

v

121

VI

154

I1

165

I11

134

IR PMR

58-60

Ho@P-

UV

Picrate

Water

OH

Homo HO

OH

113

Ethanol

UV

Paperchromatography

558

LEROYB. TOWNSEND TABLE I1 (Continued) [ab,

Imidazole m o i e t 9

G~YCOB moiety* Y~

MP, OC

Recryet solvent

der (solvent)c

Spectra

Mhod

Method of prepe

Ref

0

HO 0

As above

As above

*O

sintering Ethanol-water 175-180, and melting 216

-40 (e)

I

39

Sintering at Ethanol-water 175-180, melting a t 215-216 dec

+44 (e)

I

39

132-133

Ethanol, thenEtzO and petr ether (40-60°)

VI

39

232-233 146-148

Ethanol-pyridine Aqueous ethanol 88 monohydrate

VI

VI

39 39

VI

39

I

37

VI

37

I

91

OAc Ac

As above

AcOCHz As above A OAc HOCH, As above

208-210 dec

Methanol-water

As above

184-185

EthanOl-Water

As above

218-220 (rapid heating)

Water

215-216

Ethanol-water

+17

(8)

VI

37

246-248

Ethanol

+55 (f)

VI

37

$34 (a)

VI

39

VI

39

VI

80

VI

80

VI

154

IV

154

-4 (a)

Ad)CH1

HO

OH

As above

HO HO HO As above

&?-

A

AcO

OAc

As above HO

A s above

&+-

* &*

Ad)

Sintering a t Ethanol-water 165-170 and melb ing at 224-225 dec 158-189 Ethanol

OAc

FH3 AuCI,

144-145

HO

AcO

232 dec

Ethanol

OAc 180-182

A"co HO

As above

OH

93-95

AcO

OAc

IMIDAZOLE NUCLEOSIDES AND NUCLEOTIDES

559

TABLEI1 (Continued) bh RWWlt

Imidazole moietfl

Glycowl moiety*

MP, O C

204 O\

solvent

deg (solvent)c

Method of Spectra

Mhcd

Ethanol

prep'

Ref

111

132

V

177

V

177

I11

32

P

CH3 CH,

Hd

dH

w

6%

243-244 dec

uv

Methanol

IR

F

0

Hoco HO

As above

175-177

Methanol

148-150

Ethanol

Adco AcO

UV

Paperchromatography

I

28

UV

Paperchromatography

I

28

VI

95

VI

164

HC1 salt

I

34

Paperchromatography

I

35

I1

168

I

80

VI

168

VI

171

I1

51

OH

99-100

OAc

-0.6 (a)

uv +11.2 (f)

IR

CCL and petr ether

As above

206-207

AdCH2

176

+ & J

A

'

OAc

HO

OH

Ethanol

Diethyl ether and water

Hoco 152

Residue triturated with ethyl acetate

0

uv Pptd out of water with ethanol Hb

OH

Bariumsaltand paper chromatography

560

LEROYB. TOWNSEND TABLE I1 (Continued) Glycosyl moietyb HOCH, 0

0

As above

MP, 'C

161-162

ID,

Method of prepd

Ref

Ethyl acetate

VI

168

Methanol

I1

168

VI VI VI

60 60 60

I

39

I

39

I

96

VI

95

I

85

la

I r 5 h z o l e lnoietjP

Recryst solvent

deg (solvent)'

Spectra

Misod

O Y CHa C&

ca8m 0

223-225

AS above

dec

O

.d

F

o

207-209 198-200 130, solid-

Methanol Methanol Dilute ethanol

Neut equiv Neut equiv Dipicrate

ify then melting a t 174AcOCHz

As above

176 123

Methanol

168-167

Methanol

116-118

Methanol

Glass

f 2 2 . 6 (f)

uv

UV

I

Pape;chromatography

As above 164-165

Methanol

Hoco As above

A8 above

+i?

255-256

Methanol

uv

VI

28

115-118

Ethanol

uv

I

28

185-187

Methanol

uv

VI

28

149-150

Methanol

I

28

HO As above

0 The position of glycosidic attachment to the imidazole moiety can be easily determined by vkual inspection, and all compounds are of the p configuration unless they possess a wavy line a t the anomeric center which denotes either an anomeric mixture or a compound of unknown or undetermined anomeric configuration. * The abbreviation -OAc denotes -OCOCHa. c Solvents used in the determinstion of optical rotations appear as letters in parentheses: (a) water, (b) methanol, (c) 0.1 M sodium bicarbonate, (d) 4: 1 water-pyridine, (e) pyridine, ( f ) chloroform, ( g ) ethanol, (h) 80% ethanol, (i)24% sulfuric acid. d I R = infrared; W = ultraviolet; PMR = proton magnetic resonance. e Key to the method of preparation: I, condensation of heavy metal salt of preformed imidazole with acylglycosyl halide; 11, ring closure of glycosylamine; 111, degradation or ring opening of purine nucleoside or nucleotide; IV, acid-catalyzed fusion; V, naturally occurring or enzymatic synthesis; VI, transformation of a preformed imidazole nucleoside or nucleotide.

IMIDAZOLE NUCLEOSIDES AND XUCLEOTIDES ACKNOWLEDGMENTS.--The author wishes to express his sincere appreciation to Professor Roland K. Robins for encouragement, for a critical reading of the manuscript, and for many valuable suggestions. The author is grateful to Dr. Ralph L. Shriner for the opportunity to prepare this manuscript and appreciates the cooperation of a number of colleagues, especially R. J. Rousseau and A. F. Lewis. He also expresses his gratitude for the continuous encouragement and assistance of his wife, Sammy, and to Miss Dorlene Kearl for preparation of the manuscript. The author is indebted to the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health, Public Health Service, for financial support on Research Contract P H 43-65-1041. VII. REFERENCES (1) Abdel-Latif, A. A,, and Alivisatos, S. G. A., J . Biol. Chem., 236, 2710 (1961). (2) Abdel-Latif, A. A., and Alivisatos, S. G. A., Biochim. Bwphys. Acta, 51,398 (1961). (3) Aebi, A., Helv. Chim. Acta, 39, 1495 (1956). (4) Ahmad, F., Missimer, P., and Moat, A. G., Can. J . Biochem., 43, 1723 (1965). (5) A jinomoto Co. Inc., Japanese Patent 3550 (1962); Chem. Abstr., 58, 5012f (1963). (6) Ajinomoto Co. Inc., French Patent 1,375,784 (Oct 23, 1964); Chem. Abstr., 63, 18999g (1965). (7) Ajinomoto Co. Inc., Dutch Patent 6,409,142 (Feb 17, 1965); Chem. Abstr., 63, 57313 (1965); Dutch Patent 6,409,133 (Feb 8, 1965); Chem. Abstr., 63, 3029a (1965); Dutch Patent 6,409,806 (March 1, 1956); Chem. Abstr., 63, 10055c (1965). (8) Ajinomoto Co. Inc., Japanese Patent 1534 (Feb 4, 1966); Chem. Abstr., 64, 12781e (1966). (9) Alivisatos, S. G. A., Federation Proc., 17, 180 (1958). (10) Alivisatos, S. G. A., Nature, 181, 271 (1958). (11) Alivisatos, S. G. A., Nature, 183, 1034 (1959). (12) Alivisatos, S. G. A., Federation Proc., 24, 769 (1965). (13) Alivisatos, S. G. A,, Abdel-Latif, A. A., Ungar, F., and Mourkides, G. A., Nature, 199, 907 (1963). (14) Alivisatos, S. G. A., and LaMantia, L., Biochem. Biophys. Res. Commun., 2, 164 (1960). (15) Alivisatos, S. G. A,, LaMantia, L., and Matijevitch, B. L., Biochim. Biophys. Acta, 58, 201 (1962). (16) Alivisatos, S. G. A., LaMantia, L., Ungar, F., and Matijevitch, B. L., J. Biol. Chem., 237, 1212 (1962). (17) Alivisatos, S. G. A,, LaMantia, L., Ungar, F., and Savich, B., Biochim. Biophys. Acta, 30, 660 (1958). (18) Alivisatos, S. G. A,, Ungar, F., Lukacs, L., and LaMantia, L., J . Biol. Chem., 235, 1742 (1960). (19) Alivisatos, S. G. A., Ungar, F., and Mourkides, G. A., Nature, 211, 187 (1966). (20) Alivisatos, S. G. A., and Woolley, D. W., J . Am. Chem. SOC.,77, 1065 (1955). (21) Alivisatos, S. G. A., and Woolley, D. W., J. Biol. Chem., 221, 651 (1956). (22) Allesbrook, W. E., Gulland, J. &I., and Story, L. F., J . Chem. SOC.,232 (1942). (23) Ames, B. N., Martin, R. G., and Garry, B. J., J . Biol. Chem., 236, 2019 (1961). (24) Ames, B. N., and Mitchell, H. K., J . Am. Chem. SOC., 74, 252 (1952).

561

Atkinson, M. R., Jackson, J. F., Morton, R. K., and Murray, A. W., Nature, 196, 35 (1962). Baddiley, J., and Buchanan, J. G., Ann. Rept. Chem. SOC., 54, 329 (1957). Baddiley, J., Buchanan, J. G., Hardy, F. E., and Stewart, J., Proc. Chem. SOC.,149 (1957). Baddiley, J., Buchanan, J. G., Hardy, F. E., and Stewart, J., J . Chem. SOC.,2893 (1959). Baddiley, J., Buchanan, J. G., Hayes, D. H., and Smith, P. A., J . Chem. SOC.,3743 (1958). Baddiley, J., Buchanan, J. G., Hodges, R., and Prescott, J. F., J . Chem. SOC.,4769 (1957). Baddiley, J., Buchanan, J. G., and Osbourne, G. O., J . Chem. SOC.,3606 (1958). Baker, B. R., and Joseph, J. P., J . Am. Chem. SOC.,77, 15 (1955). Battersby, A. R., and Openshaw, H. T., “The Alkaloids,” Vol. 111, R. H. F. Manske and H. L. Holmes, Ed., Academic Press, New York, N. Y., 1953, Chapter 20. Bauer, H., Biochim. Biophys. Acta, 30, 219 (1958). Bauer, H., J. Org. Chem., 27, 167 (1962). Baugh, C. M., and Shaw, E. N., Biochim. Biophys. Acta, 114, 213 (1966). Baxter, R. A., McLean, A. C., and Spring, F. S., J . Chem. SOC.,523 (1948). Baxter, R. A,, and Spring, F. S., J . Chem. SOC.,232 (1945). Baxter, R. A., and Spring, F. S., J . Chem. SOC.,378 (1947). Ben-Ishai, R., Bergmann, E. D., and Volcani, B. E., Nature, 168, 1124 (1951). Bergmann, E., and Heimhold, H., J . Chem. SOC.,505 (1936). Bernstein, H., J . Gen. Microbiol., 25, 41 (1961). Bratton, A. C., and Marshall, E. K., J . Bwl. Chem., 128, 537 (1939). Broom, A. D., Townsend, L. B., Jones, J. W., and Robins, R.K.,Biochemistry, 3, 494 (1964). Brown, D. D., Tomchick, R., and Axelrod, J., J . Bwl. Chem., 234, 2948 (1959). Buchanan, J. G., Dekker, C. A., and Long, A. G., J. Chem. SOC.,3162 (1950). Buchanan, J. M., and Hartman, S. C., Aduan. Enzymol., 21, 199 (1959). Buchanan, J. M., and Schulman, M. P., J . Biol. Chem., 202, 241 (1953). Burns, V. W., Science, 146, 1056 (1964). Carrington, R., Shaw, G., and Wilson, D. V., Tetrahedron Letters, 2861 (1964). Carrington, R., Shaw, G., and Wilson, D. V., J . Chem. SOC.,6864 (1965). Chamberlain, N., Cutts, N. S., and Rainbow, C., J . Gen. Microbiol., 7, 54 (1952). Chamberlain, N., and Rainbow, C., J. Gen. Microbwl., 11, 180 (1954). Crowley, G. M., Federation Proc., 19, 309 (1960). Crowley, G. M., J . Biol. Chem., 239, 2593 (1964). Darnall, K. R., and Townsend, L. B., J. Heterocyclic Chem., 3, 371 (1966). Debus, H., Ann., 107, 199 (1858). de la Haba, G., and Cantoni, G. L., J . Biol. Chem., 234, 603 (1959). Djerassi, C., Bankiewicz, C., Kapoor, A. L., and Riniker, B., Tetrahedron, 2, 168a (1958). Djerassi, C., Herran, J., Khastjir, H. N., Riniker, B., and Roma, J., J . Org. Chem., 21, 1510(1956). Ellis, G. P., Epstein, C., Fitzmaurice, C., Golberg, L., and Lord, G. €I., J . Pharm. Pharmacol., 16, 400 (1964).

562

LEROYB. TOWNSEND

(62) Fernandes, J. F., Castellani, O., and Plese, M., Biochem. Biophys. Res. Commun., 3, 679 (1960). (63) Fernandes, J. F., Castellani, O., and Plese, M., Ciencia Cult. (Sa0 Paulo), 13, 87 (1961); Chern. Abstr., 57, 13071i (1962). (64) Flaks, J. G., and Buchanan, J. M., J. Am. Chem. Soc., 76, 2275 (1954). (65) Flaks, J. G., Erwin, M. J., and Buchanan, J. M., J. BWZ. Chem., 228, 201 (1957). (66) Flaks, J. G., Erwin, M. J., and Buchanan, J. M., J. BWZ. Chem., 229, 603 (1957). (67) Flaks, J. G., Warren, L., and Buchanan, J. M., J. BWZ. Chem., 228, 215 (1957). (68) Fox, J. J., and Wempen, I., Advan. Carbohydrate Chem., 14, 283 (1959). (69) Friedman, H., and Moat, A. G., Arch. Bwchem. Bwphys., 78, 146 (1958). (70) Gallo, G. C., Pasqualucci, C. R., Radaelli, P., and Lancina, G. C., J. Org. Chem., 29, 862 (1964). (71) Goldthwait, D. A., Peabody, R. A., and Greenberg, G. R., J. Am. Chem. Soc., 76, 5258 (1954). (72) Gots, J. S., Nature, 172, 256 (1953). (73) Gots, J. S., and Gollub, E. G., Proc. NatZ. Acad. Sci., U.S., 43, 826 (1957). (74) Gots, J. S., and Gollub, E. G., Proc. SOC.Ezptl. Bid. Med., 101, 638 (1959). (75) Greenberg, G. R., J. BWl. Chem., 190, 611 (1951). (76) Greenberg, G. R., J. Am. Chem. Soc., 74, 6307 (1952). (77) Greenberg, G. R., J. BWZ. Chem., 219, 423 (1956). (78) Greenberg, G. R., and Spilman, E. L., J. BWZ. Chem., 219, 411 (1956). (79) Grunberg-Manago, M., Ann. Rev. Bwchem., 31,301 (1962). (80) Gulland, J. M., and Macrae, T. F., J. Chem. Soc., 662 (1933). (81) Hall, R., Biochim. Biophys. Acta, 61, 530 (1962). (82) Hanes, C. S., and Isherwood, F. A., Nature, 164, 1107 (1949). (83) Hantzsch, A., Ann., 249, 1 (1888). (84) Hantzsch, A., and Besch, C. H., Ann., 323, 23 (1902). (85) Hartman, S. C., and Buchanan, J. M., Ann. Rev. Biochem., 28, 365 (1959). (86) Hartman, S. C., and Buchanan, J. M., J. BWZ. Chem., 234, 1812 (1959). (87) Hartman, S. C., Levenberg, B., and Buchanan, J. M., J. Am. Chem. SOC.,77, 501 (1955). (88) Hartman, S. C., Levenberg, B., and Buchanan, J. M., J. Bid. Chem., 221, 1057 (1956). (89) Hiatt, H. H., J. CZin. Invest., 37, 1453 (1958). (90) Howard, G. A., Lythgoe, B., and Todd, A. R., J. Chem. Soc., 1052 (1947). (91) Howard, G. A,, McLean, A. C., Newbold, G. I., Spring, F. S., and Todd, A. R., J. Chem. Soc., 232 (1949). (92) Huang, H. T., Biochemistry, 4, 58 (1965). (93) Hunter, G., andNelson, J. A., Can. J. Res., 19b, 296(1941). (94) Ikehara, M., and Muneyama, K., Chem. Pharm. BuZZ. (Tokyo), 14, 46 (1966). (95) Ikehara, M., Nakaeawa, N., and Nakayama, H., Chem. Pharm. BuZZ. (Tokyo), 10, 660 (1962). (96) Ishikawa, F., Nomura, A,, Ueda, T., Ikehara, M., and Mizuno, Y., Chem. Pharm. BUZZ (Tokyo), 8, 380 (1960). (97) Kalckar, H. M., Fortschr. Chem. Org. Naturstofe, 9, 389 (1952). (98) Karjala, S. A., J. Am. Chem. Soc., 77, 504 (1955). (99) Karjala, S. A., Turnquest, B. W., and Schayer, R. W., J. Bid. Chem., 219, 9 (1956). (100) King, M. E., and Carter, C. E., Biochim. Biophys. Acta, 44, 232 (1960).

(101) Klopotowski, T., Luzzati, M., and Slonimski, P., Bwchem. Bwphys. Res. Commun., 3, 150 (1960). (102) Koessler, K. K., and Hanke, M. T., J. BWZ. Chem., 39, 497 (1919). (103) Korn, E. D., and Buchanan, J. M., J. BWZ. Chem., 217, 183 (1955). (104) Leonard, N. J., and Laursen, R. A., J. Am. Chem. Soc., 85, 2026 (1963). (105) Levenberg, B., and Buchanan, J. M., J. Am. Chem. SOC., 78, 504 (1956). (106) Levenberg, B., and Buchanan, J. M., J. BWZ. Chem., 224, 1005 (1957). (107) Levenberg, B., and Buchanan, J. M., J. BWZ. Chem., 224, 1019 (1957). (108) Levene, P. A., and Jacobs, W. A., Ber., 42, 2474 (1909). (109) Liakopoulou, A., and Alivisatos, S. G. A., J. Bid. Chem., 240, 3110 (1965). (110) Litchfield, G. J., and Shaw, G., Chem. Commun., 563 (1965). (111) Lones, D. P., Rainbow, C., and Woodward, J. D., J. Gen.MicrobWZ., 19,46 (1958). (112) Love, S. H., J. Bacterial., 72,628 (1956). (113) Love, S. H., and Gots, J. S., J. BWZ. Chem., 212,647 (1955). (114) Love, S. H., and Levenberg, B., Bwchim. Bwphys. Acta, 35, 367 (1959). (115) Lowy, B. A., and Williams, M. K., J. BWZ. Chem., 235, 2924 (1960). (116) Lowy, B. A., Williams, M. K., and London, I. M., J. BWZ. Chem., 236, 1442 (1961). (117) Lowy, B. A., Williams, M. K., and London, I. M., J. BWZ. Chem., 237, 1622 (1962). (118) Lukens, L. N., and Buchanan, J. M., Federation Proc., 15, 305 (1956). (119) Lukens, L. N., and Buchanan, J. M., J. Am. Chem. Soc., 79, 1511 (1957). (120) Lukens, L. N., and Buchanan, J. M., J. Bid. Chem., 234, 1791 (1959). (121) Lukens, L. N., and Buchanan, J. M., J. Bid. Chem., 234, 1799 (1959). (122) Lukens, L. N., and Flaks, J. G., Methods EnzymoZ., 6, 696 (1963). (123) MacNutt, W. S., Bwchem. J., 50, 384 (1952). (124) Martin, R. G., J. BWZ. Chem., 238, 257 (1963). (125) Michelson, A. M., “The Chemistry of Nucleosides and Nucleotides,” Academic Press Inc., New York, N. Y., 1963. (126) Michelson, A. M., “The Chemistry of Nucleosides and Nucleotides,” Academic Press Inc., New York, N. Y., 1963, p 20, ref 74. (127) Miller, R. W., and Buchanan, J. M., J. Bid. Chem., 237, 485 (1962). (128) Miller, R. W., Lukens, L. N., and Buchanan, J. M., J. Am. Chem. Soc., 79, 1573 (1957). (129) Miller, R. W., Lukens, L. N., and Buchanan, J. M., J. BWZ. Chem., 234, 1806 (1959). (130) Mitsugi, K., Okumura, S., Shiro, T., and Takahashi, M., Agr. Bid. Chem. (Tokyo), 29, 1104 (1965). (131) Moat, A. G., Wilkins, C. N., and Friedman, H., J. BWZ. Chem., 223, 985 (1956). (132) Montgomery, J. A., Hewson, K., Clayton, S. J., and Thomas, H. J., J. Org. Chem., 31, 2202 (1966). (133) Montgomery, J. A., and Thomas, H. J., Advan. Carbohydrate Chem., 17, 301 (1962). (134) Montgomery, J. A., and Thomas, H. J., J. Org. Chem., 28, 2304 (1963). (135) Montgomery, J. A., and Thomas, H. J., J. Am. Chem. SOC., 87, 5442 (1965).

IMIDAZOLE NUCLEOSIDES AND NUCLEOTIDES (136) Montgomery, J. A., and Thomas, H. J., J . Org. Chem., 30, 494 (1965). (137) Moyed, H. S., and Magasanik, B., J . Biol. Chem., 235, 149 (1960). (138) Muraoka, S., Inoue, M., and Yamasaki, H., Nature, 190, 532 (1960). (139) Muraoka, S., Sugiyama, M., and Yamasaki, H., Nature, 196,441 (1962); Biochem. Pharmacal., 14, 27 (1965). (140) Pauly, H., 2. Physiol. Chem., 42, 508 (1904). (141) Perry, T. L., Hansen, S., Bar, H. P., and RlacDougall, L., Science, 152, 776 (1966). (142) Power, F. B., and Callan, T., J . Chem. SOC.,99, 1993 (1911). (143) Pyman, F., J. Chem. Soc., 97, 1814 (1910). (144) Rabinowits, J. C., and Pricer, W. E., Jr., Federation PTOC., 14, 266 (1955). (145) Rabinowitz, J. C., and Pricer, W. E., Jr., J . Am. Chem. SOC.,78, 5702 (1956). (146) Ralph, R. K., and Shaw, G., J . Chem. SOC.,1877 (1956). (147) Raman, S., Reddy, J., and Lipscomb, W. N., Acta Cryst., 16, 364 (1963). (148) Raman, S., Reddy, J., Lipscomb, W. N., Kapoor, A. L., and Djerassi, C., Tetrahedron Letters, 357 (1962). (149) Reichard, P., Advan. Enzymol., 21, 263 (1959). (150) Robinson, J. D., and Green, J. P., Nature, 203, 1178 (1964). (151) Robinson, J. D., and Green, J. P., Federation PTOC.,24, 777 (1965). (152) Rogers, D., King, T. E., and Cheldelin, V. H., J . BacterioZ., 80, 787 (1960). (153) Rousseau, R. J., Townsend, L. B., and Robins, R. K., Biochemistry, 5 , 756 (1966). (154) Rousseau, R. J., Townsend, L. B., and Robins, R. K,, Chem. Commun., 265 (1966). (155) Rousseau, R. J., Townsend, L. B., and Robins, R. K., unpublished observations. (156) Sato, T., Shimidate, T., and Ishido, Y., J . Chem. SOC. Japan, Ind. Chem. Sect., 81,1440 (1960), and subsequent papers. (157) Schayer, R. W., Physiol. Rev., 39, 116 (1959). (158) Schayer, R. W., and Cooper, J. A. D., J . Appl. Physiol., 6, 481 (1956). (159) Schulmann, M. P., and Buchanan, J. M., J . Biol. Chem., 196, 573 (1952). (160) Scott, J. L., J . Clin. Invest., 41, 67 (1962). (161) Shaw, E., J . Am. Chem. SOC.,80, 3899 (1958). (162) Shaw, E., J. Am. Chem. SOC.,81, 6021 (1959). (163) Shaw, E., J . Am. Chem. SOC.,83, 4770 (1961). (164) Shaw, G., and Warrener, R. N., PTOC.Chern. SOC.,193 (1958). (165) Shaw, G., Warrener, R. N., Butler, D. N., and Ralph, R. K., J . Chem. SOC.,1648 (1959). (166) Shaw, G., Warrener, R. N., Maguire, M. H., and Ralph, R. K., J . Chem. SOC.,2294 (1958). (167) Shaw, G., and Wilson, D. V., PTOC. Chem. Soc., 381 (1961).

(168) (169) (170) (171) (172) (173) (174) (175) (176) (177) (178) (179) (180) (181) (182) (183) (184) (185) (186) (187) (188) (189) (190) (191) (192) (193) (194) (195) (196) (197) (198)

563

Shaw, G., and Wilson, D. V., J . Chem. Soc., 2937 (1962). Shaw, G., and Wilson, D. V., PTOC. Chem. Soc., 115 (1962). Shaw, G., and Wilson, D. V., J . Chem. Soc., 1077 (1963). Shaw, G., Wilson, D. V., and Green, C. P., J . Chem. Soc., 2650 (1964). Shedlovsky, A. E., and Magasanik, B., J . BWl. Chem., 237, 3725 (1962). Shiro, T., Agr. BWZ. Chem. (Tokyo), 25, 350 (1961). Shiro, T., Yamanoi, A., Konishi, S., Okumura, S., and Takahashi, M., Agr. Biol. Chem. (Tokyo), 26, 785 (1962). Shive, W., Ackermann, W. W., Gordon, M., Getzendander, M. E., and Eakin, R., J . Am. Chem. SOC.,69,725 (1947). Shuster, L., J . Bid. Chem., 238, 3344 (1963). Smith, D. W. E., and Ames, B. N., J . Biol. Chem., 239, 1848 (1964). Smith, D. W. E., and Ames, B. N., J . Bid. Chem., 240, 3056 (1965). Smith, L. H., Jr., and Yates, P., J . Am. Chem. Soc., 76, 6080 (1954). Snyder, S. H., and Axelrod, J., Federatwn PTOC.,24, 774 (1965). Snyder, S. H., Axelrod, J., and Bauer, H., J . Pharmacal. Ezptl. Therap., 144, 373 (1964). Stetten, M. R., and Fox, C. L., Jr., J . Biol. Chem., 161, 333 (1945). Stevens, M. A,, Smith, H. W., and Brown, G. B., J . Am, Chem. Soc., 81, 1734 (1959). Tabor, H., and Hayaishi, O., J . Am. Chem. Soc., 77, 505 (1955). Tener, G. M., J . Am. Chem. SOC.,83, 159 (1961). Thompson, R. Y., Paul, J., and Davidson, J. N., Bwchem. J., 69, 553 (1958). Tomisek, A. J., Kelly, H. J., Reid, M. R., and Skipper, H. E., Arch. Biochem. Biophys., 76, 45 (1958). Townsend, L. B., and Robins, R. K., J . Am. Chem. SOC., 84, 3008 (1962). Townsend, L. B., and Robins, R. K., J . Am. Chem. SOC., 85, 243 (1963). Townsend, L. B., and Robins, R. K., J . Heterocyclic Chem., 3, 241 (1966). Townsend, L. B., Robins, R. K., Loeppky, R. N., and Leonard, N. J., J. Am. Chem. SOC.,86, 5320 (1964). Townsend, L. B., Rousseau, R. J., and Robins, R. K., unpublished observations. Warren, L., Flaks, J. G., and Buchanan, J. M., J . Biol. Chem., 229, 627 (1957). Weaver, J. M., and Shive, W., J . Am. Chem. Soc., 75, 4628 (1953). Webb, M., Biochem. J., 70,472 (1958). Windaus, A,, Ber., 42, 758 (1909). Woodward, J. D., and Rainbow, C., J. Gen. Microbial., 25, 141 (1961). Wyngaarden, J. D., Jones, 0. W., and Ashton, D. M., Atti Congr. Lega Intern. Reumatismo, IO', Rome, 1, 249 (1961); Chem. Abstr., 61, 9880 (1964).